| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Neagle Matthew | Chief Operating Officer | 411 FIRST AVENUE SOUTH, SUITE 501, SEATTLE | /s/Matthew Cullen as Attorney-in-fact for Matthew Neagle | 11 Sep 2025 | 0001837336 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PRCH | Common Stock | Sale | -$1.03M | -55K | -5.21% | $18.69 | 1M | 09 Sep 2025 | Direct | F1, F2 |
| transaction | PRCH | Common Stock | Options Exercise | $3.49K | +1.28K | +0.13% | $2.73 | 1M | 10 Sep 2025 | Direct | |
| transaction | PRCH | Common Stock | Options Exercise | $15.1K | +4.58K | +0.46% | $3.30 | 1.01M | 10 Sep 2025 | Direct | |
| transaction | PRCH | Common Stock | Options Exercise | $23.2K | +7.05K | +0.7% | $3.30 | 1.01M | 10 Sep 2025 | Direct | |
| transaction | PRCH | Common Stock | Options Exercise | $102K | +7.67K | +0.76% | $13.23 | 1.02M | 10 Sep 2025 | Direct | |
| transaction | PRCH | Common Stock | Options Exercise | $522 | +252 | +0.02% | $2.07 | 1.02M | 10 Sep 2025 | Direct | |
| transaction | PRCH | Common Stock | Options Exercise | $602 | +291 | +0.03% | $2.07 | 1.02M | 10 Sep 2025 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PRCH | Stock Option (right to buy) | Options Exercise | $0 | -1.28K | -100% | $0.00 | 0 | 10 Sep 2025 | Common Stock | 1.28K | $2.73 | Direct | F3 |
| transaction | PRCH | Stock Option (right to buy) | Options Exercise | $0 | -4.58K | -78% | $0.00 | 1.29K | 10 Sep 2025 | Common Stock | 4.58K | $3.30 | Direct | F4 |
| transaction | PRCH | Stock Option (right to buy) | Options Exercise | $0 | -7.05K | -100% | $0.00 | 0 | 10 Sep 2025 | Common Stock | 7.05K | $3.30 | Direct | F5 |
| transaction | PRCH | Stock Option (right to buy) | Options Exercise | $0 | -7.67K | -60.7% | $0.00 | 4.97K | 10 Sep 2025 | Common Stock | 7.67K | $13.23 | Direct | F6 |
| transaction | PRCH | Stock Option (right to buy) | Options Exercise | $0 | -252 | -95.45% | $0.00 | 12 | 10 Sep 2025 | Common Stock | 252 | $2.07 | Direct | F7 |
| transaction | PRCH | Stock Option (right to buy) | Options Exercise | $0 | -291 | -100% | $0.00 | 0 | 10 Sep 2025 | Common Stock | 291 | $2.07 | Direct | F7 |
| Id | Content |
|---|---|
| F1 | The reporting person used some of the proceeds from the sale of the issuer's shares of common stock to fund the exercise of the options disclosed in Table II. |
| F2 | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.65 to $18.76 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F3 | The stock options vested as follows: (i) 25% of the award vested on July 1, 2019 and (ii) the remainder of the award vested in 36 equal monthly installments thereafter. |
| F4 | The stock options vested as follows: (i) 25% of the award vested on September 1, 2020, with 25% of the award vesting in 6 equal monthly installments thereafter and (ii) 25% of the award vested March 1, 2021, with the remaining 25% of the award vesting in 36 equal monthly installments thereafter. |
| F5 | The stock options vested as follows: (i) 25% of the award vested March 1, 2020, (ii) 25% of the award vested on March 1, 2021, and (iii) the remainder of the award vested in 36 equal monthly installments thereafter. |
| F6 | The stock options vested as follows: (i) 25% of the award vested December 31, 2020, (ii) 25% of the award vested on December 31, 2021, and (iii) the remainder of the award vested in 35 equal monthly installments thereafter. |
| F7 | The stock options vested as follows: (i) 25% of the award vested on April 1, 2019 and (ii) the remainder of the award vested in 36 equal monthly installments thereafter. |